FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793638865> ?p ?o ?g. }

• W2793638865 endingPage "342.e6" @default.
• W2793638865 startingPage "329" @default.
• W2793638865 abstract "Extrinsic signals are implicated in breast cancer resistance to HER2-targeted tyrosine kinase inhibitors (TKIs). To examine how microenvironmental signals influence resistance, we monitored TKI-treated breast cancer cell lines grown on microenvironment microarrays composed of printed extracellular matrix proteins supplemented with soluble proteins. We tested ∼2,500 combinations of 56 soluble and 46 matrix microenvironmental proteins on basal-like HER2+ (HER2E) or luminal-like HER2+ (L-HER2+) cells treated with the TKIs lapatinib or neratinib. In HER2E cells, hepatocyte growth factor, a ligand for MET, induced resistance that could be reversed with crizotinib, an inhibitor of MET. In L-HER2+ cells, neuregulin1-β1 (NRG1β), a ligand for HER3, induced resistance that could be reversed with pertuzumab, an inhibitor of HER2-HER3 heterodimerization. The subtype-specific responses were also observed in 3D cultures and murine xenografts. These results, along with bioinformatic pathway analysis and siRNA knockdown experiments, suggest different mechanisms of resistance specific to each HER2+ subtype: MET signaling for HER2E and HER2-HER3 heterodimerization for L-HER2+ cells." @default.
• W2793638865 created "2018-03-29" @default.
• W2793638865 creator A5007033122 @default.
• W2793638865 creator A5007992461 @default.
• W2793638865 creator A5014860176 @default.
• W2793638865 creator A5028899187 @default.
• W2793638865 creator A5036039450 @default.
• W2793638865 creator A5037619159 @default.
• W2793638865 creator A5038157510 @default.
• W2793638865 creator A5042879883 @default.
• W2793638865 creator A5050876541 @default.
• W2793638865 creator A5053854002 @default.
• W2793638865 creator A5060566909 @default.
• W2793638865 creator A5062658603 @default.
• W2793638865 creator A5067332257 @default.
• W2793638865 creator A5084233435 @default.
• W2793638865 creator A5084319641 @default.
• W2793638865 creator A5084824340 @default.
• W2793638865 creator A5084892113 @default.
• W2793638865 creator A5086775172 @default.
• W2793638865 date "2018-03-01" @default.
• W2793638865 modified "2023-10-17" @default.
• W2793638865 title "Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes" @default.
• W2793638865 cites W1490349467 @default.
• W2793638865 cites W1852676669 @default.
• W2793638865 cites W1890402826 @default.
• W2793638865 cites W1974694769 @default.
• W2793638865 cites W1980039397 @default.
• W2793638865 cites W1981898048 @default.
• W2793638865 cites W1987117672 @default.
• W2793638865 cites W1990418094 @default.
• W2793638865 cites W1994238901 @default.
• W2793638865 cites W1999025555 @default.
• W2793638865 cites W2000269004 @default.
• W2793638865 cites W2004403900 @default.
• W2793638865 cites W2005162043 @default.
• W2793638865 cites W2012034410 @default.
• W2793638865 cites W2017081079 @default.
• W2793638865 cites W2023673693 @default.
• W2793638865 cites W2024651005 @default.
• W2793638865 cites W2045950562 @default.
• W2793638865 cites W2055624262 @default.
• W2793638865 cites W2069213920 @default.
• W2793638865 cites W2070026305 @default.
• W2793638865 cites W2078250780 @default.
• W2793638865 cites W2084694142 @default.
• W2793638865 cites W2084888420 @default.
• W2793638865 cites W2095156669 @default.
• W2793638865 cites W2096283457 @default.
• W2793638865 cites W2097698108 @default.
• W2793638865 cites W2100348249 @default.
• W2793638865 cites W2103484524 @default.
• W2793638865 cites W2108541764 @default.
• W2793638865 cites W2109780841 @default.
• W2793638865 cites W2110444464 @default.
• W2793638865 cites W2115330997 @default.
• W2793638865 cites W2118385988 @default.
• W2793638865 cites W2121469024 @default.
• W2793638865 cites W2126983941 @default.
• W2793638865 cites W2127258026 @default.
• W2793638865 cites W2128307445 @default.
• W2793638865 cites W2132535297 @default.
• W2793638865 cites W2137018685 @default.
• W2793638865 cites W2139444209 @default.
• W2793638865 cites W2140593657 @default.
• W2793638865 cites W2143231467 @default.
• W2793638865 cites W2143799421 @default.
• W2793638865 cites W2155560234 @default.
• W2793638865 cites W2157840751 @default.
• W2793638865 cites W2161687028 @default.
• W2793638865 cites W2162946128 @default.
• W2793638865 cites W2163035374 @default.
• W2793638865 cites W2165003903 @default.
• W2793638865 cites W2165226517 @default.
• W2793638865 cites W2167279371 @default.
• W2793638865 cites W2275389390 @default.
• W2793638865 cites W2403325187 @default.
• W2793638865 cites W2412372305 @default.
• W2793638865 cites W2515932604 @default.
• W2793638865 cites W2616596696 @default.
• W2793638865 cites W2620174055 @default.
• W2793638865 cites W901049929 @default.
• W2793638865 doi "https://doi.org/10.1016/j.cels.2018.02.001" @default.
• W2793638865 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5927625" @default.
• W2793638865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29550255" @default.
• W2793638865 hasPublicationYear "2018" @default.
• W2793638865 type Work @default.
• W2793638865 sameAs 2793638865 @default.
• W2793638865 citedByCount "64" @default.
• W2793638865 countsByYear W27936388652018 @default.
• W2793638865 countsByYear W27936388652019 @default.
• W2793638865 countsByYear W27936388652020 @default.
• W2793638865 countsByYear W27936388652021 @default.
• W2793638865 countsByYear W27936388652022 @default.
• W2793638865 countsByYear W27936388652023 @default.
• W2793638865 crossrefType "journal-article" @default.
• W2793638865 hasAuthorship W2793638865A5007033122 @default.
• W2793638865 hasAuthorship W2793638865A5007992461 @default.

• next